Wong Ryan Ho-Yan 4

What Happened
Ryan Ho-Yan Wong, Chief Financial Officer of Sarepta Therapeutics (SRPT), had 256 shares withheld by the company on 2026-03-11 to satisfy tax withholding related to vested restricted stock units. The shares were valued at $17.03 each, for a total disposition of $4,360. This was a company-withheld tax payment (routine), not an open-market sale.

Key Details

• Transaction date: 2026-03-11
• Price per share: $17.03; Shares withheld/disposed: 256; Total value: $4,360
• Shares owned after transaction: not specified in the provided filing excerpt
• Footnote: F1 — shares were withheld by the company to satisfy tax withholding obligations related to RSUs granted March 10, 2025
• Filing date: 2026-03-13; appears to be filed on time (within the standard reporting window)
• Transaction code: F (payment of exercise price or tax liability via share withholding)

Context
This was a cashless tax-withholding disposition tied to RSU vesting, a common administrative action and not necessarily a signal of insider sentiment. The dollar amount is modest relative to typical insider trades.